RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • Allergan says a 2nd suitor wants to buy it, adding to takeover drama

    Allergan says a 2nd suitor wants to buy it, adding to takeover drama
    Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it. Allergan did not identify the new...
  • Oklahoma Supreme Court puts abortion restriction on hold

    The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court. The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
  • Allergan loses bid to block Ackman from voting on takeover

    Allergan loses bid to block Ackman from voting on takeover
    Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. Allergan had accused Ackman's Pershing Square Capital Management...
  • OraSure expects milestones in its Ebola research

    OraSure expects milestones in its Ebola research
    By the end of the year, Bethlehem-based OraSure expects to announce key research milestones in determining if its OraQuick rapid in-home HIV test can be adapted to screen patients for Ebola. The company has consulted with the federal Food and Drug...
  • A balloon for obesity: an option between medication and surgery?

    A balloon for obesity: an option between medication and surgery?
    For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it's a little help, but not enough. And...
  • Allergan, fighting off Valeant, discussing merger with another firm

    Allergan, fighting off Valeant, discussing merger with another firm
    Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals. For six months Irvine-based Allergan has fought off an unsolicited takeover bid from Valeant...
  • AbbVie board calls off Shire acquisition

    AbbVie board calls off Shire acquisition
    North Chicago-based drugmaker AbbVie has pulled the plug on its plan to buy Dublin-based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules. Shire stands to be paid a break-up fee of about $1.64...
  • Raw deal for AbbVie, but does anyone care?

    Raw deal for AbbVie, but does anyone care?
    AbbVie got hosed on its aborted Shire deal. Let's get that up top. It's also very hard to feel sorry for it. Sure, the North Chicago-based pharmaceutical business failed to score Adderall and the Irish outfit behind it. You can make all the cracks you...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • AbbVie partners with Google to develop new drugs for aging

    AbbVie partners with Google to develop new drugs for aging
    A startup backed by Google, the Silicon Valley powerhouse whose innovations range from its eponymous search engine to self-driving cars, is teaming up with a North Chicago drug company to develop treatments for diseases tied to aging. Drugmaker AbbVie...